Natalie Morris, MPH
Project Manager
Natalie Morris is a Project Manager at ANSIRH working on studies related to alternative methods of medication abortion provision in the U.S. She has extensive experience in study implementation and quantitative analytic methods. Natalie hopes her work will continue to contribute to an evidence base that informs policy on improving reproductive health equity. Previously, Natalie worked for the UC Berkeley Bixby Center for Population, Health, and Sustainability. She received her MPH in Epidemiology / Biostatistics and BA in Molecular & Cell Biology from the University of California, Berkeley.
The latest research
See allFebruary 29, 2024
Abortion pills on TV: An exploratory study of the associations between abortion plotline viewership and beliefs regarding in-clinic and self-managed medication abortion
Herold S, Natalie Morris, MPH, Biggs MA, Schroeder R, Kaller S, Sisson G. Abortion pills on TV: An exploratory study of the associations between abortion plotline viewership and beliefs regarding in-clinic and self-managed medication abortion. Contraception. February 2024; https://doi.org/10.1016/j.contraception.2024.110416.
February 22, 2023
Feasibility and Acceptability of At-Home Routine Pregnancy Testing in the United States: A Pilot Study
Natalie Morris, MPH, Ehrenreich K, Gurazada T, Grossman D. Feasibility and Acceptability of At-Home Routine Pregnancy Testing in the United States: A Pilot Study. Women's Health Issues. February 2023; https://doi.org/10.1016/j.whi.2023.01.002.
May 5, 2022
Comprehension of an Over-the-Counter Drug Facts Label Prototype for a Mifepristone and Misoprostol Medication Abortion Product
Biggs MA, Ehrenreich K, Natalie Morris, MPH, Blanchard K, Bustamante CK, Choimorrow SY, Hauser D, Hernandez Y, Kapp N, Kromenaker T, Moayedi G, Perritt J, Ralph LJ, Raymond EG, Valladares ES, Kari White, Grossman D. Comprehension of an Over-the-Counter Drug Facts Label Prototype for a Mifepristone and Misoprostol Medication Abortion Product. Obstetrics & Gynecology. May 2022; DOI: 10.1097/AOG.0000000000004757.